Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Auteur de référence en rhumatologie
21 articles scientifiques publiés — un praticien à la pointe de la recherche
Référence presse grand public
Cité 1 fois dans les médias — pédagogie reconnue
Délais de RDV courts dans la région
136 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
21
21 articles ont été cités au moins 21fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
2 465
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
183
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
36
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Inserm · Inserm · Université Paris-Saclay
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Sequential multimodal therapy in chronic thromboembolic pulmonary hypertension with mixed anatomical lesions: a proof of concept
2023ArticleEuropean Respiratory Journal
Highlights from the International Chronic Thromboembolic Pulmonary Hypertension Congress 2021
2023ArticleEuropean Respiratory Review
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study
2022ArticleThe Lancet Respiratory Medicine
Sexual dysfunction among males and females with bipolar disorder and healthy subjects: The burden of illness severity
2022ArticleBipolar Disorders
Management of Etonogestrel implant migration into the pulmonary artery
2022ArticleContraception
Pulmonary thromboendarterectomy: The Marie Lannelongue Hospital experience
2022ArticleAnnals of Cardiothoracic Surgery
Hospital costs of Balloon Pulmonary Angioplasty (BPA) procedure and management for CTEPH patients: An observational study based on the French national hospital discharge database (PMSI)
2021ArticlePLoS ONE
Pulmonary Hemorrhage Revealing Multiple Vascular Malformations in a Child with KCNT1 Developmental Epileptic Encephalopathy
2021ArticleThe Journal of Pediatrics
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
HOPITAL MARIE LANNELONGUE
133 AV DE LA RESISTANCE, 92350 LE PLESSIS ROBINSON
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
📰 Cardiologie Pratique · 14/11/2022
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxPUG1XT1Y3V2VSV3NfWkJPa3Vxa1JrQnZ5dlBjVkFYRHBlYnFIRFQ5bm5hWDhRYzhpRkFkejBZNFVqV2FGUXF6dHFVMkdXZDJybmtXaFMtdkVKRmxFYWZpdENCelVlT3pRX2NYaWMwcjYwOWFGMW9tLUQ3NGswUDl4MWM0NnJMRmYzSnN4c1R2S09SZVRWczZR?oc=5" target="_blank">Quantification du volum
European respiratory review : an official journal of the European Respiratory Society · 2017
Chronic thromboembolic pulmonary hypertension (CTEPH) is thought to result from incomplete resolution of pulmonary thromboemboli that undergo organisation into fibrous tissue within pulmonary arterial branches, filling pulmonary arterial lumina with collagenous obstructions. The treatment of choice is pulmonary endarterectomy (PEA) in CTEPH centres, which has low post-operative mortality and good long-term survival. For patients ineligible for PEA or who have recurrent or persistent pulmonary hypertension after surgery, medical treatment with riociguat is beneficial. In addition, percutaneous balloon pulmonary angioplasty (BPA) is an emerging option, and promises haemodynamic and functional benefits for inoperable patients. In contrast to conventional angioplasty, BPA with undersized balloons over guide wires exclusively breaks intraluminal webs and bands, without dissecting medial vessel layers, and repeat sessions are generally required. Observational studies report that BPA improves haemodynamics, symptoms and functional capacity in patients with CTEPH, but controlled trials with long-term follow-up are needed. Complications include haemoptysis, wire injury, vessel dissection, vessel rupture, reperfusion pulmonary oedema, pulmonary parenchymal bleeding and haemorrhagic pleural effusions. This review summarises the available evidence for BPA, patient selection, recent technical refinements and periprocedural imaging, and discusses the potential future role of BPA in the management of CTEPH.
The Lancet. Respiratory medicine · 2022
European heart journal · 2023
Abstract The current treatment algorithm for chronic thromboembolic pulmonary hypertension (CTEPH) as depicted in the 2022 European Society of Cardiology (ESC)/European Respiratory Society (ERS) guidelines on the diagnosis and treatment of pulmonary hypertension (PH) includes a multimodal approach of combinations of pulmonary endarterectomy (PEA), balloon pulmonary angioplasty (BPA) and medical therapies to target major vessel pulmonary vascular lesions, and microvasculopathy. Today, BPA of &gt;1700 patients has been reported in the literature from centers in Asia, the US, and also Europe; many more patients have been treated outside literature reports. As BPA becomes part of routine care of patients with CTEPH, benchmarks for safe and effective care delivery become increasingly important. In light of this development, the ESC Working Group on Pulmonary Circulation and Right Ventricular Function has decided to publish a document that helps standardize BPA to meet the need of uniformity in patient selection, procedural planning, technical approach, materials and devices, treatment goals, complications including their management, and patient follow-up, thus complementing the guidelines. Delphi methodology was utilized for statements that were not evidence based. First, an anatomical nomenclature and a description of vascular lesions are provided. Second, treatment goals and definitions of complete BPA are outlined. Third, definitions of complications are presented which may be the basis for a standardized reporting in studies involving BPA. The document is intended to serve as a companion to the official ESC/ERS guidelines.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Circulation. Cardiovascular interventions · 2025 · Clinical Trial, Phase III
Gerges C, Jevnikar M, Brenot P, Savale L, et al.
Respiratory medicine and research · 2023 · Letter
Combet M, Mouren D, Motiejunaite J, Bunel V, et al.
Annals of cardiothoracic surgery · 2022 · Journal Article
Mercier O, Dubost C, Delaporte A, Genty T, et al.
PloS one · 2021 · Journal Article
Cottin V, Bensimon L, Raguideau F, Chaize G, et al.
Open journal of cardiovascular surgery · 2018 · Case Reports
Bardet J, Fabre D, Brenot P, Watkins C, et al.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2015 · Clinical Trial
Berland J, Lefèvre T, Brenot P, Fajadet J, et al.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2015 · Letter
Brenot P, Waliszewski MW, Tho NT, Houyel L, et al.
Presse medicale (Paris, France : 1983) · 2014 · Journal Article
Mercier O, Fadel E, Mussot S, Fabre D, et al.
Archives of cardiovascular diseases · 2026 · Journal Article
Albenque G, Valdeolmillos E, Foray C, Cachanado M, et al.
Pediatric cardiology · 2015 · Journal Article
Ponthier L, Brenot P, Lambert V, Petit J, et al.
Pediatric cardiology · 2015 · Journal Article
Bonnet M, Petit J, Lambert V, Brenot P, et al.
The Lancet. Respiratory medicine · 2022 · Clinical Trial, Phase III
Jaïs X, Brenot P, Bouvaist H, Jevnikar M, et al.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery · 2021 · Comparative Study
Fabre D, Mougin J, Mitilian D, Cochennec F, et al.
Revista portuguesa de cardiologia · 2021 · Journal Article
Calé R, Ferreira F, Pereira AR, Repolho D, et al.
Circulation. Cardiovascular interventions · 2014 · Journal Article
Baruteau AE, Petit J, Lambert V, Gouton M, et al.
European respiratory review : an official journal of the European Respiratory Society · 2023 · Journal Article
Simonneau G, Fadel E, Vonk Noordegraaf A, Toshner M, et al.
European respiratory review : an official journal of the European Respiratory Society · 2017 · Journal Article
Lang I, Meyer BC, Ogo T, Matsubara H, et al.
The European respiratory journal · 2025 · Letter
Jevnikar M, Brenot P, Kularatne M, Rodière A, et al.
Bipolar disorders · 2022 · Journal Article
Dargél AA, Mosconi E, Volant S, Taieb D, et al.
Journal of the American College of Cardiology · 2025 · Journal Article
Lang IM, Brenot P, Bouvaist H, Fadel E, et al.
European heart journal · 2023 · Journal Article
Lang IM, Andreassen AK, Andersen A, Bouvaist H, et al.
Circulation. Cardiovascular interventions · 2014 · Journal Article
Baruteau AE, Petit J, Lambert V, Gouton M, et al.